
AGL
agilon health inc.
$1.13
-$0.03(-2.59%)
27
Overall
--
Value
27
Tech
--
Quality
Market Cap
$480.73M
Volume
6.60M
52W Range
$0.71 - $6.08
Target Price
$2.05
Order:
Income Statement
Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|
REVENUE | ||||||
Total Revenue | $1.8B | $2.4B | $4.3B | $6.1B | ||
Total Revenue | $1.8B | $2.4B | $4.3B | $6.1B | ||
COST OF GOODS SOLD | ||||||
Cost of Revenue | -- | $2.3B | -- | -- | ||
GROSS PROFIT | ||||||
Gross Profit | $1.8B | $111.4M | $4.3B | $6.1B | ||
OPERATING EXPENSES | ||||||
Operating Expenses | $2.2B | $216.7M | $301.8M | $293.4M | ||
Selling, General & Administrative | $455.8M | $207.8M | $285.8M | $268.9M | ||
General & Administrative Expenses | $455.8M | $207.8M | $285.8M | $268.9M | ||
Salaries & Wages | $292.4M | $28.4M | $69.5M | -- | ||
Depreciation & Amortization | $14.5M | $8.9M | $16.0M | $24.5M | ||
Depreciation & Amortization | $14.5M | $8.9M | $16.0M | $24.5M | ||
Amortization | $55.4M | $18.4M | $63.8M | $72.8M | ||
Other Operating Expenses | $-109.5M | $-35.0K | $-79.0K | $-192.0K | ||
OPERATING INCOME | ||||||
Operating income | $-394.0M | $-105.4M | $-232.1M | $-292.1M | ||
EBITDA | $-164.8M | $-72.4M | $-194.3M | $-225.4M | ||
NON-OPERATING ITEMS | ||||||
Interest Expense (Non-Operating) | $6.1M | $4.5M | $6.7M | -- | ||
Net Non-Operating Interest Income/Expense | $-6.1M | $4.5M | $-6.7M | -- | ||
Gain on Sale of Securities | -- | $14.5M | $27.9M | $19.2M | ||
Other Income/Expense | $1.7B | $19.2M | $-44.3M | $-49.5M | ||
Other Special Charges | $-1.7B | $13.9M | $27.8M | $34.5M | ||
SPECIAL ITEMS | ||||||
Special Income Charges | $-58.0K | $-3.0M | $4.0M | $-3.6M | ||
Impairment of Capital Assets | -- | -- | -- | $3.6M | ||
PRE-TAX INCOME | ||||||
EBIT | $-179.5M | $-86.2M | $-214.5M | $-249.9M | ||
Pre-Tax Income | $-404.6M | $-90.7M | $-194.5M | $-248.8M | ||
INCOME TAX | ||||||
Tax Provision | $886.0K | $1.6M | $791.0K | $1.5M | ||
NET INCOME | ||||||
Net Income | $-406.5M | $-106.6M | $-262.6M | $-260.2M | ||
Net Income (Continuing Operations) | $-186.5M | $-92.3M | $-215.3M | $-251.3M | ||
Net Income (Discontinued Operations) | $-406.5M | $-106.6M | $-262.6M | $-260.2M | ||
Net Income (Common Stockholders) | $-406.5M | $-106.6M | $-262.6M | $-260.2M | ||
TOTALS | ||||||
Total Expenses | $2.2B | $2.5B | $301.8M | $293.4M | ||
SHARE & EPS DATA | ||||||
Average Shares Outstanding | $372.9M | $408.2M | $408.9M | $411.0M | ||
Average Shares Outstanding (Diluted) | -- | $408.2M | $408.9M | $411.0M | ||
Shares Outstanding | $401.2M | $413.1M | $409.5M | $412.3M | ||
Basic EPS | $-1.09 | $-0.26 | $-0.64 | $-0.63 | ||
Basic EPS (Continuing Operations) | $-1.09 | $-0.26 | $-0.48 | $-0.61 | ||
Diluted EPS | $-1.09 | $-0.26 | $-0.64 | $-0.63 | ||
Diluted EPS (Continuing Operations) | -- | $-0.26 | $-0.48 | $-0.61 | ||
OTHER METRICS | ||||||
Basic Discontinuous Operations | -- | -- | $-0.16 | $-0.02 | ||
Diluted Discontinuous Operations | -- | -- | $-0.16 | $-0.02 | ||
Earnings from equity interest | $-6.8M | $10.7M | $16.5M | $15.0M | ||
Earnings From Equity Interest Net Of Tax | $-6.8M | $10.7M | $16.5M | $15.0M | ||
Gain On Sale Of P P E | -- | $-5.5M | -- | -- | ||
Gains Loss On Disposal Of Discontinued Operations | $1.7M | $-26.0K | $-47.5M | $-8.8M | ||
Interest Expense Operating | $-4.8M | $-3.7M | $-5.8M | $-4.6M | ||
Minority Interests | $300.0K | $311.0K | $207.0K | $-50.0K | ||
Net Income Discontinuous Operations | $-1.3M | $-26.0K | $-47.5M | $-8.8M | ||
Other Gain Loss From Disposition Of Discontinued Operations | $-3.0M | $-14.6M | $-67.5M | $-9.8M | ||
Other Gand A | $455.8M | $207.8M | $285.8M | $268.9M | ||
Othspecchg | $58.0K | $3.0M | $-4.0M | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | AGL | $1.13 | -2.6% | 6.60M |
3 | ||||
4 | ||||
5 | ||||
6 |